Druggability of mortalin for cancer and neuro-degenerative disorders

Current Pharmaceutical Design

Volumn 19, Issue 3, 2013, Pages 418-429

  Deocaris, Custer C ^a,b   Lu, Wen Jing ^c   Kaul, Sunil C ^a   Wadhwa, Renu ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cancer; Chaperone; Mortalin; Target; Therapy

Indexed keywords

1 ETHYL 2 [[3 ETHYL 5 (3 METHYLBENZOTHIAZOLIN 2 YLIDENE) 4 OXOTHIAZOLIDIN 2 YLIDENE]METHYL]PYRIDINIUM CHLORIDE; 5 AZA 2' DEOXYCYTIDINE; AMINO ACID; HEAT SHOCK PROTEIN 70; MAGNESIUM; MITOCHONDRIAL PROTEIN; MORTALIN 1; MORTALIN 2; UNCLASSIFIED DRUG; WITHANIA SOMNIFERA EXTRACT;

ALLELE; ANIMAL CELL CULTURE; ARTICLE; BRAIN DISEASE; BRAIN TUMOR; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL AGING; CELL MEMBRANE; CELL NUCLEUS; COLON CANCER; COLORECTAL CANCER; CYTOSOL; ENDOPLASMIC RETICULUM; GENETIC ANALYSIS; HUMAN; HYPOMAGNESEMIA; KIDNEY DISEASE; LIVER CELL CARCINOMA; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PANCREAS CANCER; PEROXISOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RENAL MAGNESIUM WASTING; STOMACH CANCER;

EID: 84876706133     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161213804143680     Document Type: Article

References (143)

1. Wadhwa R, Kaul SC, Ikawa Y, Sugimoto Y. Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. J Biol Chem 1993; 268(9): 6615-21.
2. Wadhwa R, Kaul SC, Sugimoto Y, Mitsui Y. Induction of cellular senescence by transfection of cytosolic mortalin cDNA in NIH 3T3 cells. J Biol Chem 1993; 268(30): 22239-42.
3. Wadhwa R, Kaul SC, Mitsui Y, Sugimoto Y. Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts. Exp Cell Res 1993; 207(2): 442-8.
4. Kaul SC, Wadhwa R, Matsuda Y, et al. Mouse and human chromosomal assignments of mortalin, a novel member of the murine hsp70 family of proteins. FEBS Lett 1995; 361(2-3): 269-72.
5. Wadhwa R, Akiyama S, Sugihara T, Reddel RR, Mitsui Y, Kaul SC. Genetic differences between the pancytosolic and perinuclear forms of murine mortalin. Exp Cell Res 1996; 226(2): 381-6.
6. Kaul SC, Duncan E, Sugihara T, Reddel RR, Mitsui Y, Wadhwa R. Structurally and functionally distinct mouse hsp70 family members Mot-1 and Mot-2 proteins are encoded by two alleles. DNA Res 2000; 7(3): 229-31.
7. Kaul SC, Duncan EL, Englezou A, et al. Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein. Oncogene 1998; 17(7): 907-11.
8. Kaul SC, Yaguchi T, Taira K, Reddel RR, Wadhwa R. Overexpressed mortalin (mot-2)/mthsp70/GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts. Exp Cell Res 2003; 286(1): 96-101.
9. Webster TJ, Naylor DJ, Hartman DJ, Hoj PB, Hoogenraad NJ. cDNA cloning and efficient mitochondrial import of pre-mtHSP70 from rat liver. DNA Cell Biol 1994; 13(12): 1213-20.
10. Bhattacharyya T, Karnezis AN, Murphy SP, et al. Cloning and subcellular localization of human mitochondrial hsp70. J Biol Chem 1995; 270(4): 1705-10.
11. Craig EA, Kramer J, Kosic-Smithers J. SSC1, a member of the 70-kDa heat shock protein multigene family of Saccharomyces cerevisiae, is essential for growth. Proc Natl Acad Sci USA 1987; 84(12): 4156-60.
12. Geissler A, Rassow J, Pfanner N, Voos W. Mitochondrial import driving forces: enhanced trapping by matrix Hsp70 stimulates translocation and reduces the membrane potential dependence of loosely folded preproteins. Mol Cell Biol 2001; 21(20): 7097-104.
13. Kawai A, Nishikawa S, Hirata A, Endo T. Loss of the mitochondrial Hsp70 functions causes aggregation of mitochondria in yeast cells. J Cell Sci 2001; 114 (19): 3565-74.
14. Schilke B, Williams B, Knieszner H, et al. Evolution of mitochondrial chaperones utilized in Fe-S cluster biogenesis. Curr Biol 2006; 16(16): 1660-5.
15. Wadhwa R, Sugihara T, Yoshida A, et al. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res 2000; 60(24): 6818-21.
16. Widodo N, Deocaris CC, Kaur K, et al. Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway. J Gerontol A Biol Sci Med Sci 2007; 62(3): 246-55.
17. Widodo N, Kaur K, Shrestha BG, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumorinhibitory factor and the first molecular insights to its effect. Clin Cancer Res 2007; 13(7): 2298-306.
18. Gao R, Yaguchi T, Horimoto K, Ishii T, Kaul SC, Wadhwa R. Identification of anti-cancer shRNAs based on the staining pattern of mortalin. Tiss Cult Res Commun 2010; 29: 147-53.
19. Wadhwa R, Takano S, Robert M, et al. Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem 1998; 273(45): 29586-91.
20. Deocaris CC, Kaul SC, Wadhwa R. On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60. Cell Stress Chaperones 2006; 11(2): 116-28.
21. Kaul SC, Deocaris CC, Wadhwa R. Three faces of mortalin: a housekeeper, guardian and killer. Exp Gerontol 2007; 42(4): 263-74
22. Deocaris CC, Kaul SC, Wadhwa R. The versatile stress protein mortalin as a chaperone therapeutic agent. Protein Pept Lett 2009; 16(5): 517-29.
23. Wadhwa R, Takano S, Kaur K, et al. Upregulation of mortalin/ mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer 2006; 118(12): 2973-80.
24. Jin J, Hulette C, Wang Y, et al. Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol Cell Proteomics 2006; 5(7): 1193-204.
25. Liu Y, Liu W, Song XD, Zuo J. Effect of GRP75/mthsp70/PBP74/mortalin overexpression on intracellular ATP level, mitochondrial membrane potential and ROS accumulation following glucose deprivation in PC12 cells. Mol Cell Biochem 2005; 268(1-2): 45-51.
26. Xu L, Voloboueva LA, Ouyang Y, Emery JF, Giffard RG. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab 2009; 29(2): 365-74.
27. Yoo JY, Ryu J, Gao R, et al. (2010) Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adenooncolytic virus. J Gene Med 2010; 12(7): 586-95.
28. Lu WJ, Lee NP, Kaul SC, et al. Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death Differ 2011; 18(6): 1046-56.
29. Lu WJ, Lee NP, Wadhwa R, Luk JM. In: Kaul SC, Wadhwa R, editors. Mortalin Biology: Life, Stress and Death, Springer 2012. pp. 267-78
30. Deocaris CC, Shrestha BG, Kraft DC, et al. Geroprotection by glycerol: insights to its mechanisms and clinical potentials. Ann N Y Acad Sci 2006; 1067: 488-92.
31. Milenkovic D, Muller J, Stojanovski D, Pfanner N, Chacinska A. Diverse mechanisms and machineries for import of mitochondrial proteins. Biol Chem 2007; 388(9): 891-7.
32. Wiedemann N, van der Laan M, Hutu DP, Rehling P, Pfanner N. Sorting switch of mitochondrial presequence translocase involves coupling of motor module to respiratory chain. J Cell Biol 2007; 179(6): 1115-22.
33. D'Silva P, Liu Q, Walter W, Craig EA. Regulated interactions of mtHsp70 with Tim44 at the translocon in the mitochondrial inner membrane. Nat Struct Mol Biol 2004; 11(11): 1084-91.
34. Strub A, Zufall N, Voos W. The putative helical lid of the Hsp70 peptide-binding domain is required for efficient preprotein translocation into mitochondria. J Mol Biol 2003; 334(5): 1087-99.
35. Neupert W, Herrmann JM. Translocation of proteins into mitochondria. Annu Rev Biochem 2007; 76: 723-49.
36. Lu WJ, Lee NP, Kaul SC, et al. Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. Int J Cancer 2011;129(8): 1806-14.
37. Bertelsen EB, Chang L, Gestwicki JE, Zuiderweg ER. Solution conformation of wild-type E. coli Hsp70 (DnaK) chaperone complexed with ADP and substrate. Proc Natl Acad Sci U S A 2009; 106(21): 8471-6.
38. Eisenberg E, Greene LE. Multiple roles of auxilin and hsc70 in clathrin-mediated endocytosis. Traffic 2007; 8(6): 640-6.
39. Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci 2005; 62(6): 670-84.
40. Deocaris CC, Widodo N, Shrestha BG, et al. Mortalin sensitizes human cancer cells to MKT-077-induced senescence. Cancer Lett 2007; 252(2): 259-69.
41. Grover A, Priyandoko D, Gao R, et al. Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence. Int J Biochem Cell Biol 2012; 44(3): 496-504.
42. Sriram M, Osipiuk J, Freeman B, Morimoto R, Joachimiak A. Human Hsp70 molecular chaperone binds two calcium ions within the ATPase domain. Structure 1997; 5(3): 403-14.
43. Smock RG, Rivoire O, Russ WP, et al. An interdomain sector mediating allostery in Hsp70 molecular chaperones. Mol Syst Biol 2010; 6: 414.
44. Luo WI, Dizin E, Yoon T, Cowan JA. Kinetic and structural characterization of human mortalin. Protein Expr Purif 2010; 72(1): 75-81.
45. Zhu X, Zhao X, Burkholder WF, et al. Structural analysis of substrate binding by the molecular chaperone DnaK. Science 1996; 272(5268): 1606-14.
46. Kaul SC, Reddel RR, Mitsui Y, Wadhwa R. An N-terminal region of mot-2 binds to p53 in vitro. Neoplasia 2001; 3(2): 110-4.
47. Mayer MP, Rudiger S, Bukau B. Molecular basis for interactions of the DnaK chaperone with substrates. Biol Chem 2000; 381(9-10): 877-85.
48. Deocaris CC, Yamasaki K, Kaul SC, Wadhwa R. Structural and functional differences between mouse mot-1 and mot-2 proteins that differ in two amino acids. Ann N Y Acad Sci 2006; 1067: 220-3.
49. Macario AJ, Conway de Macario E. Sick chaperones and ageing: a perspective. Ageing Res Rev 2002; 1(2): 295-311.
50. Kaul SC, Takano S, Reddel RR, Mitsui Y, Wadhwa R. Transcriptional inactivation of p53 by deletions and single amino acid changes in mouse mot-1 protein. Biochem Biophys Res Commun 2000; 279(2): 602-6.
51. Ran Q, Wadhwa R, Kawai R, et al. Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75. Biochem Biophys Res Commun 2000; 275(1): 174-9.
52. Gupta RS, Ramachandra NB, Bowes T, Singh B. Unusual cellular disposition of the mitochondrial molecular chaperones Hsp60, Hsp70 and Hsp10. Novartis Found Symp 2008; 291: 59-68; discussion 69-73, 137-40.
53. Schwarzer C, Barnikol-Watanabe S, Thinnes FP, Hilschmann N. Voltage-dependent anion-selective channel (VDAC) interacts with the dynein light chain Tctex1 and the heat-shock protein PBP74. Int J Biochem Cell Biol 2002; 34(9): 1059-70.
54. Chakrabarti R, Shepardson S, Karmakar M, et al. Extramitochondrial localization and likely reproductive function of a female-transmitted cytochrome c oxidase subunit II protein. Dev Growth Differ 2009; 51(5): 511-9.
55. Kuroda Y, Mitsui T, Kunishige M, et al. Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 2006; 15(6): 883-95.
56. Domanico SZ, DeNagel DC, Dahlseid JN, Green JM, Pierce SK. Cloning of the gene encoding peptide-binding protein 74 shows that it is a new member of the heat shock protein 70 family. Mol Cell Biol 1993; 13(6): 3598-610.
57. Poindexter BJ, Pereira-Smith O, Wadhwa R, Buja LM, Bick RJ. 3D Reaconstruction and localization of mortalin by deconvolution microscopy. Micros Anal 2002; 89: 21-3.
58. Singh B, Soltys BJ, Wu ZC, Patel HV, Freeman KB, Gupta RS. Cloning and some novel characteristics of mitochondrial Hsp70 from Chinese hamster cells. Exp Cell Res 1997; 234(2): 205-16.
59. Soltys BJ, Gupta RS. Mitochondrial-matrix proteins at unexpected locations: are they exported? Trends Biochem Sci 1999; 24(5): 174-7.
60. Soltys BJ, Gupta RS. Mitochondrial proteins at unexpected cellular locations: export of proteins from mitochondria from an evolutionary perspective. Int Rev Cytol 2000; 194: 133-96.
61. Wadhwa R, Pereira-Smith OM, Reddel RR, Sugimoto Y, Mitsui Y, Kaul SC. Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp Cell Res 1995; 216(1): 101-6.
62. Deocaris CC, Widodo N, Ishii T, Kaul SC, Wadhwa R. Functional significance of minor structural and expression changes in stress chaperone mortalin. Ann N Y Acad Sci 2007; 1119: 165-75.
63. Wadhwa R, Taira K, Kaul SC. Mortalin: a potential candidate for biotechnology and biomedicine. Histol Histopathol 2002; 17(4): 1173-7.
64. Walker C, Bottger S, Low B. Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model. Am J Pathol 2006; 168(5): 1526-30.
65. Walker C, Bottger SA, Mulkern J, Jerszyk E, Litvaitis M, Lesser M. Methods for karyotyping and for localization of developmentally relevant genes on the chromosomes of the purple sea urchin, Strongylocentrotus purpuratus. Biol Bull 2009; 217(3): 306-12.
66. Wadhwa R, Yaguchi T, Hasan MK, Taira K, Kaul SC. Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their role in control of cellular proliferation. Biochem Biophys Res Commun 2003; 302(4): 735-42.
67. Vandermoere F, Yazidi-Belkoura IE, Demont Y, et al. Proteomics exploration reveals that actin is a signaling target of the kinase Akt. Mol Cell Proteomics 2007; 6(1): 114-24.
68. Cicchillitti L, Di Michele M, Urbani A, et al. Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57. J Proteome Res 2009; 8(4): 1902-12.
69. Yang L, Guo W, Zhang Q, et al. Crosstalk between Raf/MEK/ERK and PI3K/AKT in suppression of Bax conformational change by Grp75 under glucose deprivation conditions J Mol Biol. 2011; 414(5): 654-66.
70. Ohtsuka R, Abe Y, Fujii T, et al. Mortalin is a novel mediator of erythropoietin signaling. Eur J Haematol 2007; 79(2): 114-25.
71. Mizukoshi E, Suzuki M, Misono T, et al. Cell-cycle dependent tyrosine phosphorylation on mortalin regulates its interaction with fibroblast growth factor-1. Biochem Biophys Res Commun 2001; 280(4): 1203-9.
72. Mizukoshi E, Suzuki M, Loupatov A, et al. Fibroblast growth factor-1 interacts with the glucose-regulated protein GRP75/mortalin. Biochem J 1999; 343 Pt 2: 461-6.
73. Ma Z, Izumi H, Kanai M, Kabuyama Y, Ahn NG, Fukasawa K. Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene 2006; 25(39): 5377-90.
74. Katayama H, Wang J, Treekitkarnmongkol W, et al. Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell 2012; 21(2): 196-211.
75. Kanai M, Ma Z, Izumi H, et al. Physical and functional interaction between mortalin and Mps1 kinase. Genes Cells 2007; 12(6): 797-810.
76. Shih YY, Lee H, Nakagawara A, et al. Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma. PLoS One 2011; 6(10): e26236.
77. Takano S, Wadhwa R, Mitsui Y, Kaul SC. Identification and characterization of molecular interactions between glucose-regulated proteins (GRPs) mortalin/GRP75/peptide-binding protein 74 (PBP74) and GRP94. Biochem J 2001; 357(Pt 2): 393-8.
78. Fransen M, Vastiau I, Brees C, Brys V, Mannaerts GP, Van Veldhoven PP. Potential role for Pex19p in assembly of PTSreceptor docking complexes. J Biol Chem 2004; 279(13): 12615-24.
79. Fransen M, Vastiau I, Brees C, Brys V, Mannaerts GP, Van Veldhoven PP. Analysis of human Pex19p's domain structure by pentapeptide scanning mutagenesis. J Mol Biol 2005; 346(5): 1275-86.
80. Matsuzono Y, Kinoshita N, Tamura S, et al. Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. Proc Natl Acad Sci U S A 1999; 96(5): 2116-21.
81. Ghaedi K, Tamura S, Okumoto K, Matsuzono Y, Fujiki Y. The peroxin pex3p initiates membrane assembly in peroxisome biogenesis. Mol Biol Cell 2000; 11(6): 2085-102.
82. van der Zand A, Braakman I, Tabak HF. Peroxisomal membrane proteins insert into the endoplasmic reticulum. Mol Biol Cell 2010; 21(12): 2057-65.
83. Kim KB, Lee JW, Lee CS, et al. Oxidation-reduction respiratory chains and ATP synthase complex are localized in detergentresistant lipid rafts. Proteomics 2006; 6(8): 2444-53.
84. Wittrup A, Zhang SH, Svensson KJ, et al. Magnetic nanoparticlebased isolation of endocytic vesicles reveals a role of the heat shock protein GRP75 in macromolecular delivery. Proc Natl Acad Sci USA 2010; 107(30): 13342-7
85. Staubach S, Hanisch FG. Lipid rafts: signaling and sorting platforms of cells and their roles in cancer. Expert Rev Proteomics 2011; 8(2): 263-77.
86. Podack ER, Tschopp J. Membrane attack by complement. Mol Immunol 1984; 21(7): 589-603.
87. Pilzer D, Saar M, Koya K, Fishelson Z. Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity. Int J Cancer 2010; 126(6): 1428-35.
88. Pilzer D, Gasser O, Moskovich O, Schifferli JA, Fishelson Z. Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin Immunopathol 2005; 27(3): 375-87.
89. Pilzer D, Fishelson Z. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis. Int Immunol 2005; 17(9): 1239-48.
90. Shelton MN, Huang MB, Ali SA, Powell MD, Bond VC. Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J Virol 2012; 86(1): 406-19.
91. Lenassi M, Cagney G, Liao M, et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells Traffic. 2010; 11(1): 110-22.
92. Hauser H, Lopez LA, Yang SJ, et al. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 2010; 7: 51.
93. Nguyen DG, Booth A, Gould SJ, Hildreth JE. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem 2003; 278(52): 52347-54.
94. Zvereff V, Wang JC, Shun K, Lacoste J, Chevrette M. Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells. Br J Cancer 2007; 97(7): 941-8.
95. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009; 9(1): 40-55.
96. Schneider M. A rational approach to maximal success rate in target discovery. Arch Pharm (Weinheim) 2004; 337(12): 625-33.
97. Soti C, Csermely P. Chaperones come of age. Cell Stress Chaperones 2002; 7(2): 186-90
98. Soti C, Csermely P. Molecular chaperones and the aging process. Biogerontology 2000; 1(3): 225-33.
99. Soti C, Csermely P. Chaperones and aging: role in neurodegeneration and in other civilizational diseases. Neurochem Int 2002; 41(6): 383-9.
100. Takano S, Wadhwa R, Yoshii Y, Nose T, Kaul SC, Mitsui Y. Elevated levels of mortalin expression in human brain tumors. Exp Cell Res 1997; 237(1): 38-45.
101. Massa SM, Longo FM, Zuo J, Wang S, Chen J, Sharp FR. Cloning of rat grp75, an hsp70-family member, and its expression in normal and ischemic brain. J Neurosci Res 1995; 40(6): 807-19.
102. Dundas SR, Lawrie LC, Rooney PH, Murray GI. Mortalin is overexpressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol 2005; 205(1): 74-81.
103. Yi X, Luk JM, Lee NP, et al. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics 2008; 7(2): 315-25.
104. Koya K, Li Y, Wang H, et al. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. Cancer Res 1996; 56(3): 538-43.
105. Propper DJ, Braybrooke JP, Taylor DJ, et al. Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours. Ann Oncol 1999; 10(8): 923-7.
106. Britten CD, Rowinsky EK, Baker SD, et al. A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077. Clin Cancer Res 2000; 6(1): 42-9.
107. Trapp S, Horobin RW. A predictive model for the selective accumulation of chemicals in tumor cells. Eur Biophys J 2005; 34(7): 959-66.
108. Modica-Napolitano JS, Brunelli BT, Koya K, Chen LB. Photoactivation enhances the mitochondrial toxicity of the cationic rhodacyanine MKT-077. Cancer Res 1998; 58(1): 71-5.
109. Maruta H, Tikoo A, Shakri R, Shishido T. The anti-RAS cancer drug MKT-077 is an F-actin cross-linker. Ann N Y Acad Sci 1999; 886: 283-4.
110. Maruta H, He H, Tikoo A, Nur-e-Kamal M. Cytoskeletal tumor suppressors that block oncogenic RAS signaling. Ann N Y Acad Sci 1999; 886: 48-57.
111. Chiba Y, Kubota T, Watanabe M, et al. MKT-077, localized lipophilic cation: antitumor activity against human tumor xenografts serially transplanted into nude mice. Anticancer Res 1998; 18(2A): 1047-52.
112. Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. J Natl Cancer Inst 2010; 102(20): 1536-46.
113. Chandeck C, Mooi WJ. Oncogene-induced cellular senescence. Adv Anat Pathol 2010; 17(1): 42-8.
114. Zuckerman V, Wolyniec K, Sionov RV, Haupt S, Haupt Y. Tumour suppression by p53: the importance of apoptosis and cellular senescence. J Pathol 2009; 219(1): 3-15. J Pathol 219, 3-15
115. Feng Z, Hu W, Rajagopal G, Levine AJ. The tumor suppressor p53: cancer and aging. Cell Cycle 2008; 7(7): 842-7.
116. Chang BD, Broude EV, Dokmanovic M, et al. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 1999; 59(15): 3761-7.
117. Barkholt L, Bregni M. Current immunotherapy for solid tumors. Immunotherapy 2009; 1(3): 483-93.
118. Widodo N, Takagi Y, Shrestha BG, Ishii T, Kaul SC, Wadhwa R. Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses. Cancer Lett 2008; 262(1): 37-47.
119. Deocaris CC, Widodo N, Wadhwa R, Kaul SC. Merger of ayurveda and tissue culture-based functional genomics: inspirations from systems biology. J Transl Med 2008; 6: 14.
120. Deocaris CC, Kaul SC, Wadhwa R. Use of ribozymes in cellular aging research. Methods Mol Biol 2007; 371: 209-26.
121. Deocaris CC, Taira K, Kaul SC, Wadhwa R. Mimotope-hormesis and mortalin/grp75/mthsp70: a new hypothesis on how infectious disease-associated epitope mimicry may explain low cancer burden in developing nations. FEBS Lett 2005; 579(3): 586-90.
122. He S, Yang L, Lv Z, et al. Molecular and functional characterization of a mortalin-like protein from Schistosoma japonicum (SjMLP/hsp70) as a member of the HSP70 family. Parasitol Res 2010; 107(4): 955-66.
123. Chen Y, Voegeli TS, Liu PP, Noble EG, Currie RW. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm Allergy Drug Targets 2007; 6(2): 91-100.
124. Shiota M, Ikeda Y, Kaul Z, Itadani J, Kaul SC, Wadhwa R. Internalizing antibody-based targeted gene delivery for human cancer cells. Hum Gene Ther 2007;18(11):1153-60.
125. Wadhwa R, Ando H, Kawasaki H, Taira K, Kaul SC. Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes. EMBO Rep 2003; 4(6): 595-601.
126. Wadhwa R, Takano S, Taira K, Kaul SC. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells. J Gene Med 2004; 6(4): 439-44.
127. Kaul SC, Aida S, Yaguchi T, Kaur K, Taira K, Wadhwa R. Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides. J Biol Chem 2005; 280(47): 39373-9.
128. Gruber J, Schaffer S, Halliwell B. The mitochondrial free radical theory of ageing--where do we stand? Front Biosci 2008; 13: 6554-79.
129. Orsini F, Migliaccio E, Moroni M, et al. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem 2004; 279(24): 25689-95.
130. Lopez-Lluch G, Irusta PM, Navas P, de Cabo R. Mitochondrial biogenesis and healthy aging. Exp Gerontol 2008; 43(9): 813-9.
131. Deocaris CC, Kaul SC, Wadhwa R. From proliferative to neurological role of an hsp70 stress chaperone, mortalin. Biogerontology 2008; 9(6): 391-403.
132. Van Laar VS, Mishizen AJ, Cascio M, Hastings TG. Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol Dis 2009; 34(3): 487-500.
133. de Mena L, Coto E, Sanchez-Ferrero E, et al. Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease. J Neural Transm 2009; 116(10): 1289-93.
134. Chiasserini D, Tozzi A, de Iure A, et al. Mortalin inhibition in experimental Parkinson's disease. Mov Disord 2011; 26(9): 1639-47
135. Burbulla LF, Schelling C, Kato H, et al. Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis. Hum Mol Genet 2010; 19(22): 4437-52.
136. Osorio C, Sullivan PM, He DN, et al. Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice. Neurobiol Aging 2007; 28(12): 1853-62.
137. Sirk D, Zhu Z, Wadia JS, et al. Chronic exposure to sub-lethal beta-amyloid (Abeta) inhibits the import of nuclear-encoded proteins to mitochondria in differentiated PC12 cells. J Neurochem 2007; 103(5): 1989-2003.
138. Santos RX, Correia SC, Wang X, et al. Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. Int J Clin Exp Pathol 2010; 3(6): 570-81.
139. Yokoyama K, Fukumoto K, Murakami T, et al. Extended longevity of Caenorhabditis elegans by knocking in extra copies of hsp70F, a homolog of mot-2 (mortalin)/mthsp70/Grp75. FEBS Lett 2002; 516(1-3): 53-7.
140. Deocaris CC, Takano S, Priyandoko D, et al. Glycerol stimulates innate chaperoning, proteasomal and stress-resistance functions: implications for geronto-manipulation. Biogerontology 2008; 9(4): 269-82.
141. Mashanov VS, Zueva OR, Rojas-Catagena C, Garcia-Arraras JE. Visceral regeneration in a sea cucumber involves extensive expression of survivin and mortalin homologs in the mesothelium. BMC Dev Biol 2010; 10: 117.
142. Conte M, Deri P, Isolani ME, Mannini L, Batistoni R. A mortalinlike gene is crucial for planarian stem cell viability. Dev Biol 2009; 334(1): 109-18.
143. Kampinga HH, Craig EA. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 2010; 11(8): 579-92.